Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jérôme Bejaud"'
Autor:
Norraseth Kaeokhamloed, Emillie Roger, Jérôme Béjaud, Nolwenn Lautram, Florence Manero, Rodolphe Perrot, Marie Briet, Chadi Abbara, Samuel Legeay
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 595 (2021)
Standard models used for evaluating the absorption of nanoparticles like Caco-2 ignore the presence of vascular endothelium, which is a part of the intestinal multi-layered barrier structure. Therefore, a coculture between the Caco-2 epithelium and H
Externí odkaz:
https://doaj.org/article/d205ce3c2445475c8ccc39dac900cb2c
Autor:
Jérôme Bejaud, Catherine Guillet, Thomas Briot, Frédéric Lagarce, Naila Bou Haidar, Emilie Roger, Sylvain Thepot, Samuel Legeay, Nolwenn Lautram
Publikováno v:
International Journal of Nanomedicine. 14:2091-2102
Background Acute myeloid leukemia mainly affects adult patients. Complete remission for patients younger than 60 years, who are candidates for standard induction therapy, is achieved in 60%-80% of cases. However, the prognosis is still poor for older
Autor:
Franck Geneviève, Marion Pitorre, Jean-Pierre Benoit, Valérie Moal, Karolina Frankova, Nolwenn Lautram, Rodolphe Perrot, Jérôme Bejaud, Claire Gazaille, Jérémie Riou, Le Thuy Trang Pham, Guillaume Bastiat
Publikováno v:
Materials Science and Engineering: C
Materials Science and Engineering: C, Elsevier, 2021, 126, pp.112188. ⟨10.1016/j.msec.2021.112188⟩
Materials Science and Engineering: C, Elsevier, 2021, 126, pp.112188. ⟨10.1016/j.msec.2021.112188⟩
Nanoparticle-loaded hydrogels are attractive pharmaceutical drug delivery systems that combine the advantages of both hydrogel (local administration and/or sustained drug release) and nanoparticle (stealthiness, targeting and decreased toxicity). The
Autor:
Santiago Daniel Palma, Guillermo G. Montich, Jean-Pierre Benoit, Gabriela Veronica Ullio Gamboa, María Lina Formica, Samuel Legeay, Jérôme Bejaud
Publikováno v:
Materials Science and Engineering: C
Materials Science and Engineering: C, Elsevier, 2021, 119, pp.111398. ⟨10.1016/j.msec.2020.111398⟩
Materials Science and Engineering: C, Elsevier, 2021, 119, pp.111398. ⟨10.1016/j.msec.2020.111398⟩
International audience; The aim of this study was to design and develop a novel hybrid formulation based on lipid nanocapsules containing bevacizumab (BVZ), an effective therapeutic antibody, on the surface and triamcinolone acetonide (TA) in the inn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9fb91b359e903cd09c06c76818d8ee
https://hal.univ-angers.fr/hal-02926008
https://hal.univ-angers.fr/hal-02926008
Autor:
Olivier Meyer, Jérôme Bejaud, Charlotte Rivière, Angélique Virgone-Carlotta, Stéphanie Briançon, Jean Paul Rieu, Kevin Matha, Thomas Dehoux, Martina Bocchiardo, Thomas Perrier, Jean-Pierre Benoit, Giovanna Lollo, Ilaria Marigo
Publikováno v:
Journal of Drug Targeting
Journal of Drug Targeting, Informa Healthcare, 2018, pp.1-12. ⟨10.1080/1061186X.2018.1547733⟩
Journal of Drug Targeting, 2019, 27 (5-6), pp.634-645. ⟨10.1080/1061186X.2018.1547733⟩
Journal of Drug Targeting, Informa Healthcare, 2019, 27 (5-6), pp.634-645. ⟨10.1080/1061186X.2018.1547733⟩
Journal of Drug Targeting, Informa Healthcare, 2018, pp.1-12. ⟨10.1080/1061186X.2018.1547733⟩
Journal of Drug Targeting, 2019, 27 (5-6), pp.634-645. ⟨10.1080/1061186X.2018.1547733⟩
Journal of Drug Targeting, Informa Healthcare, 2019, 27 (5-6), pp.634-645. ⟨10.1080/1061186X.2018.1547733⟩
International audience; In this work, a novel lipophilic 5-fluorouracil (5-FU) derivative was synthesised and encapsulated into lipid nanocapsules (LNC). 5-FU was modified with lauric acid to give a lipophilic mono-lauroyl-derivative (5-FU-C12, MW of
Autor:
Angélique Montagu, Elisabeth Rossines, Marie-Laure Joly-Guillou, Jérôme Bejaud, Patrick Saulnier, Catherine Guillet
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2016, 506 (1-2), pp.280-288. ⟨10.1016/j.ijpharm.2016.03.033⟩
International Journal of Pharmaceutics, 2016, 506 (1-2), pp.280-288. ⟨10.1016/j.ijpharm.2016.03.033⟩
International Journal of Pharmaceutics, Elsevier, 2016, 506 (1-2), pp.280-288. ⟨10.1016/j.ijpharm.2016.03.033⟩
International Journal of Pharmaceutics, 2016, 506 (1-2), pp.280-288. ⟨10.1016/j.ijpharm.2016.03.033⟩
International audience; Acinetobacter baumannii is an important nosocomial pathogen that is resistant to many commonly-used antibiotics. One strategy for treatment is the use of aromatic compounds (carvacrol, cinnamaldehyde) against A. baumannii. The
Autor:
José Hureaux, Alejandro Nieto Orellana, Jérôme Bejaud, Anna Cieślak, Jean-Pierre Benoit, Claudio J. Salomon, Nathalie Wauthoz, Michel Lafleur, Nolwenn Lautram, Guillaume Bastiat
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2017, 115, pp.31-38. ⟨10.1016/j.ejpb.2017.02.008⟩
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2017, 115, pp.31-38. ⟨10.1016/j.ejpb.2017.02.008⟩
Sterosomes (STEs), a new and promising non-phospholipidic liposome platform based on palmitic acid (PA) and cholesterol (Chol) mixtures, need to have polyethylene glycol (PEG) chains grafted to their surface in order to obtain long-circulating nanoca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2424767992572d3c94375c3be219b45c
https://hal.univ-angers.fr/hal-02515689
https://hal.univ-angers.fr/hal-02515689
Autor:
Jérôme Bejaud, Anne Clavreul, Julien Balzeau, Anne Vessières, Joël Eyer, Ngoc Trinh Huynh, Jean-Pierre Benoit, Anne-Laure Lainé, Catherine Passirani
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2012, 81 (3), pp.690-693. ⟨10.1016/j.ejpb.2012.04.012⟩
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2012, 81 (3), pp.690-693. ⟨10.1016/j.ejpb.2012.04.012⟩
In this study, a new active targeting strategy to favour ferrociphenol (FcdiOH) internalisation into brain tumour cells was developed by the use of lipid nanocapsules (LNCs) coated with a cell-internalising peptide (NFL-TBS.40-63 peptide) that intera
Autor:
Jean-Pierre Benoit, Jérôme Bejaud, Guillaume Bastiat, Yves Mély, Marion Pitorre, Carl Simonsson, Andrey S. Klymchenko
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2016, 98, pp.47-56
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2016, 98, pp.47-56. ⟨10.1016/j.ejpb.2015.10.011⟩
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2016, 98, pp.47-56
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2016, 98, pp.47-56. ⟨10.1016/j.ejpb.2015.10.011⟩
International audience; Release studies constitute a fundamental part of the nanovector characterization. However, it can be difficult to correctly assess the release of lipophilic compounds from lipid nanocarriers using conventional assays. Previous
Autor:
Isabelle Texier, Elisabetta Pancani, Jean-Luc Coll, Margaux Wiber, Jérôme Bejaud, Anne-Laure Lainé, Lucie Sancey, M. Henry, Julien Gravier, Jean-Pierre Benoit, Catherine Passirani
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society
Journal of controlled release : official journal of the Controlled Release Society, 2014, 188, pp.1-8. ⟨10.1016/j.jconrel.2014.05.042⟩
Journal of controlled release : official journal of the Controlled Release Society, 2014, 188, pp.1-8. ⟨10.1016/j.jconrel.2014.05.042⟩
International audience; The determination of the nanocarrier fate in preclinical models is required before any translation from laboratory to clinical trials. Modern fluorescent imaging techniques have gained considerable advances becoming a powerful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42adfea0ee9dff266c7c28554b617049
https://univ-angers.hal.science/hal-03179480
https://univ-angers.hal.science/hal-03179480